Sugammadex vs Placebo to Prevent Residual Neuromuscular Block

Randomized Double---Blinded, Controlled Trial to Compare the Effectiveness of Sugammadex vs. Placebo to Prevent Residual Neuromuscular Block in the Post---Anesthesia Care Unit as Evaluated With a Non---Invasive Respiratory Volume Monitor

The study is designed to determine whether patients who receive sugammadex immediately after tracheal extubation will exhibit a decrease in the incidence of postoperative residual paralysis and an associated decrease in the incidence of postoperative respiratory depression.

Inclusion Criteria:

• Patients undergoing surgery with general anesthesia
• Patients weighing > or = 80 pounds
• Patients not intubated prior to surgery
• Patients who are able to give informed consent

Exclusion Criteria:

• Patients unable to give informed consent.
• Patients whose condition will not allow for placement of the electrode PadSet of ExSpiron
• Patients who are anticipated to remain intubated in recovery period.